OmniaManufacturing Services for Novel Biologics

Cells
About the images

Company Profile

Omnia offers an array of manufacturing and process development services for companies engaged in the development of novel biologics. Our experience in many of these areas – from preclinical gene therapeutics through commercial recombinant proteins – gives Omnia a unique and specialized approach for developing manufacturing processes.

The company has both non-GMP and GMP facilities for process development through Phase I/II manufacture.


Technical Focus
:
 
- Adenovirus
- Lentivirus
- Retrovirus
- AAV
- VLP
- Other viral platforms 

Contact us to meet at our scheduled
conferences and tradeshows:
- Viral Vectors&Vaccines (Washington, DC, March 10-12, 2014)
- ASGCT Annual Meeting (Washington, DC, May 20-24, 2014)
- BIO Int. Convention (San Diego, CA, June 23-26, 2014)
- ISCGT Annual Meeting (Amsterdam, September 25-27, 2014)
- SITC Annual Meeting (National Harbor, MD, November 7-9, 2014)